ArthNow Logo
ArthNow
•2 min read•
✦Reported by Reuters

Still possible chipmaker Nexperia could reunite with Chinese operations, CEO says

Still possible chipmaker Nexperia could reunite with Chinese operations, CEO says
Source: Reuters

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Nexperia BV could still reunite with its Chinese operations, the chipmaker’s CEO told Reuters on Tuesday.
  • ✓The company split last year after Dutch state intervention.
  • ✓While Nexperia expanded in Malaysia to replace lost capacity, the CEO said, "I don't think there's anything against also holding an equity stake in China."

Story at a Glance

Category
Indian Markets
Reported By
Reuters
Reading Speed
2 Minute(s)
Market Focus
India Economy

MUNICH, Nov 10 (Reuters) - Nexperia BV could still reunite with its Chinese operations, the Dutch chipmaker's chief ‌executive told Reuters on Tuesday, even though, more than a year after geopolitical tensions split the company, the two sides now have separate businesses.

Sign up here.

"They ​are the economic owner of the shares of the company, and they can't exercise ⁠control right now. But it doesn't mean, of course, that they shouldn't be compensated fairly if a ​sale process should happen," he said.

With Tilger focused on running the business, he said negotiating a long-term ​solution was up to Wingtech's board and two Dutch court-appointed officials.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Reuters

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.